Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

A new method accurately measures nine specific hormones in human blood.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Testosterone's effects on COVID-19 are unclear and need more research.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Possible link between androgens and COVID-19 severity; more research needed.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Using finasteride with TIP extends time off period for prostate cancer patients.

Raspberry ketone lacks sufficient human research to support health benefit claims and requires more rigorous studies to confirm its safety and effectiveness.